Efficacy of liposomal antibiotic therapy in a rat infusion model of Escherichia coli peritonitis.

OBJECTIVE To compare the potential therapeutic effect of liposomal vs. free cefoxitin. DESIGN Randomized, controlled study, using a rat model of peritonitis. SETTING Government research facility. SUBJECTS Male Sprague-Dawley rats. INTERVENTIONS Rats were infused intraperitoneally with 6.5 x 10(8) colony forming units of Escherichia coli over 12 hrs. Animals were then randomized to receive intravenous saline, free cefoxitin, liposomal cefoxitin, or plain liposomes twice daily until they were killed. MEASUREMENTS AND MAIN RESULTS Free cefoxitin significantly reduced the number of E. coli after 24 hrs compared with saline treatment in both liver and spleen. However, liposomal cefoxitin further decreased the bacterial content by five-fold to ten-fold in these organs. Minimal bactericidal effect was observed in animals injected with plain liposomes. Although administration of liposomal cefoxitin for 7 days further reduced bacterial counts in liver and spleen, there was no apparent beneficial bactericidal effect of free cefoxitin over saline at 7 days. There was approximately a ten-fold reduction in bacterial content in the lungs after 24 hrs in all three treatments, but no further reduction was observed after 7 days. There was no difference in 7-day survival rate in animals treated with plain liposomes or saline (45% vs. 39%). Although survival tended to increase with free cefoxitin treatment (64%), this outcome was significantly improved with the use of liposomal cefoxitin (82%). CONCLUSIONS Liposomal cefoxitin enhanced bacterial killing in liver and spleen in this model of E. coli peritonitis. It also improved survival outcome relative to no treatment but not compared with free cefoxitin.

[1]  P. Tikuisis,et al.  Distribution of free and liposomal cefoxitin in plasma and peritoneal fluid in a porcine intra-abdominal sepsis model. , 1998, Journal of drug targeting.

[2]  P. Shek,et al.  A sustained release bacterial inoculum infusion model of intra-abdominal infection in conscious rats: bacteriology, metabolism, and histopathology. , 1996, Shock.

[3]  J. Bohnen,et al.  Liposomal cefoxitin in a porcine model of intra-abdominal sepsis: bactericidal efficacy. , 1995, Shock.

[4]  I. Brook.  Comparison of cefoxitin, cefotetan and the combination of ampicillin with sulbactam in the therapy of polymicrobial infection in mice. , 1994, The Journal of antimicrobial chemotherapy.

[5]  A. Nathens,et al.  Therapeutic options in peritonitis. , 1994, The Surgical clinics of North America.

[6]  J. Fierer,et al.  Liposome-incorporated ciprofloxacin in treatment of murine salmonellosis , 1993, Antimicrobial Agents and Chemotherapy.

[7]  A. Kresta,et al.  Distribution of Free and Liposome‐encapsulated Cefoxitin in Experimental Intra‐abdominal Sepsis in Rats , 1993, The Journal of pharmacy and pharmacology.

[8]  A. May,et al.  Anti-tumor necrosis factor antibody reduces mortality in the presence of antibiotic-induced tumor necrosis factor release. , 1993, Archives of surgery.

[9]  D. Friend,et al.  Treatment of Mycobacterium avium-intracellulare complex infection in beige mice with free and liposome-encapsulated streptomycin: role of liposome type and duration of treatment. , 1991, The Journal of infectious diseases.

[10]  L. Toledo-Pereyra,et al.  Peritonitis after cecal perforation. An experimental model to study the therapeutic role of antibiotics associated with allopurinol and catalase. , 1991, The American surgeon.

[11]  C. Baxter,et al.  Enhanced effectiveness of intraperitoneal antibiotics administered via liposomal carrier. , 1989, Archives of surgery.

[12]  I. Brook.  In vitro susceptibility and in vivo efficacy of antimicrobials in the treatment of Bacteroides fragilis-Escherichia coli infection in mice. , 1989, The Journal of infectious diseases.

[13]  J. Bohnen,et al.  Antibiotic efficacy in intraabdominal sepsis: a clinically relevant model. , 1988, Canadian journal of microbiology.

[14]  W. L. Hand,et al.  Contrasts between phagocyte antibiotic uptake and subsequent intracellular bactericidal activity , 1986, Antimicrobial Agents and Chemotherapy.

[15]  M. Stevenson,et al.  Enhanced activity of streptomycin and chloramphenicol against intracellular Escherichia coli in the J774 macrophage cell line mediated by liposome delivery , 1983, Antimicrobial Agents and Chemotherapy.

[16]  J. Meakins,et al.  Prognosis in generalized peritonitis. Relation to cause and risk factors. , 1983, Archives of surgery.

[17]  E. Wisse,et al.  UPTAKE OF LIPOSOMES BY RAT AND MOUSE HEPATOCYTES AND KUPFFER CELLS , 1983 .

[18]  C. Bucana,et al.  Analysis of the fate of systemically administered liposomes and implications for their use in drug delivery. , 1982, Cancer research.

[19]  D. Musher,et al.  Critical importance of early diagnosis and treatment of intra-abdominal infection. , 1982, Archives of surgery.

[20]  J. Bartlett,et al.  Microbial synergy in experimental intra-abdominal abscess , 1976, Infection and immunity.